125 related articles for article (PubMed ID: 16026363)
1. Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).
Shehadeh N; Bakri D; Njølstad PR; Gershoni-Baruch R
Diabet Med; 2005 Aug; 22(8):994-8. PubMed ID: 16026363
[TBL] [Abstract][Full Text] [Related]
2. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical phenotype of the p.Val226Met glucokinase gene mutation in French Canadians in Quebec, Canada.
Henderson M; Levy E; Delvin E; Losekoot M; Lambert M
Mol Genet Metab; 2007 Jan; 90(1):87-92. PubMed ID: 17079173
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients.
Dudhbhai M; Lim L; Bombard A; Juliard K; Meenakshi B; Trachelenberg Y; Weiner Z
Am J Obstet Gynecol; 2006 May; 194(5):e42-5. PubMed ID: 16647897
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population.
Malcolm JC; Lawson ML; Gaboury I; Lough G; Keely E
Diabet Med; 2006 May; 23(5):565-70. PubMed ID: 16681566
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
10. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
11. [Mutation screening of GCK gene in Chinese early-onset diabetes population].
Zheng TS; Wu SH; Yang Z; Lu HJ; Xiang KS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):671-4. PubMed ID: 16331569
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of diabetes mellitus in a rural Greek population.
Melidonis AM; Tournis SM; Kompoti MK; Lentzas IL; Roussou VR; Iraklianou SL; Michail IM; Mariolis AM
Rural Remote Health; 2006; 6(1):534. PubMed ID: 16579675
[TBL] [Abstract][Full Text] [Related]
13. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
[TBL] [Abstract][Full Text] [Related]
14. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.
Njølstad PR; Sagen JV; Bjørkhaug L; Odili S; Shehadeh N; Bakry D; Sarici SU; Alpay F; Molnes J; Molven A; Søvik O; Matschinsky FM
Diabetes; 2003 Nov; 52(11):2854-60. PubMed ID: 14578306
[TBL] [Abstract][Full Text] [Related]
15. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
[TBL] [Abstract][Full Text] [Related]
16. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.
Rubio-Cabezas O; Díaz González F; Aragonés A; Argente J; Campos-Barros A
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):245-9. PubMed ID: 18298419
[TBL] [Abstract][Full Text] [Related]
17. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
18. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A
Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723
[TBL] [Abstract][Full Text] [Related]
19. Glucokinase mutations in young children with hyperglycemia.
Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
